Nicola Miller

Lecturer Above The Bar B.Sc.,M.Sc.,Phd.

Contact Details

Lecturer Above The Bar
Surgery
NUI Galway

T: 87-4637
E: nicola.miller@nuigalway.ie
 
researcher

Biography

Dr Nicola Miller has worked as a Lecturer / Senior Research Fellow in the Discipline of Surgery, NUI Galway since 2005. Having carried out her undergraduate studies in Biotechnology at King’s College London, she completed her PhD on Imprinted Genes in Breast Cancer at UCD. Her postdoctoral work began at the National Centre for Medical Genetics, Dublin as a Locum Clinical Scientist followed by a 2 year Post-doc on hereditary breast cancer. Following a subsequent move to St James’s Hospital Dublin she was involved in the establishment of a new clinical service laboratory for molecular cancer diagnostics and worked as a Lecturer in Trinity College Dublin, before moving to Galway.

Research Interests

The goal of my research is towards a better understanding of the molecular mechanisms underlying the development of cancer and is focused on population genetics and molecular profiling approaches in particular. By understanding an individual’s inherited predisposition to disease in the context of the expressed phenotype in their tumour we hope to advance current diagnostics and therapaeutics for cancer.

Peer Reviewed Journals

  Year Publication
(2013) 'Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers'
French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O'Reilly M, Hillman KM, Betts JA, Carroll T, Bailey PJ, Dicks E, Beesley J, Tyrer J, Maia AT, Beck A, Knoblauch NW, Chen C, Kraft P, Barnes D, González-Neira A, Alonso MR, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Conroy D, Dennis J, Bolla MK, Wang Q, Hopper JL, Southey MC, Schmidt MK, Broeks A, Verhoef S, Cornelissen S, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Fasching PA, Loehberg CR, Ekici AB, Beckmann MW, Peto J, dos Santos Silva I, Johnson N, Aitken Z, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Truong T, Laurent-Puig P, Menegaux F, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Zamora MP, Arias Perez JI, Benitez J, Anton-Culver H, Brenner H, Müller H, Arndt V, Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Engel C, Brauch H, Hamann U, Justenhoven C; GENICA Network, Aaltonen K, Heikkilä P, Aittomäki K, Blomqvist C, Matsuo K, Ito H, Iwata H, Sueta A, Bogdanova NV, Antonenkova NN, Dörk T, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM; kConFab Investigators, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Lambrechts D, Peeters S, Smeets A, Floris G, Chang-Claude J, Rudolph A, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Sardella D, Couch FJ, Wang X, Pankratz VS, Lee A, Giles GG, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labrèche F, Dumont M, Teo SH, Yip CH, Ng CH, Vithana EN, Kristensen V, Zheng W, Deming-Halverson S, Shrubsole M, Long J, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Devilee P, Seynaeve C, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Klevebring D, Schoof N, Hooning MJ, Martens JW, Collée JM, Tilanus-Linthorst M, Hall P, Li J, Liu J, Humphreys K, Shu XO, Lu W, Gao YT, Cai H, Cox A, Balasubramanian SP, Blot W, Signorello LB, Cai Q, Pharoah PD, Healey CS, Shah M, Pooley KA, Kang D, Yoo KY, Noh DY, Hartman M, Miao H, Sng JH, Sim X, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Sangrajrang S, Gaborieau V, McKay J, Toland AE, Ambrosone CB, Yannoukakos D, Godwin AK, Shen CY, Hsiung CN, Wu PE, Chen ST, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Ponder BA, Nevanlinna H, Brown MA, Chenevix-Trench G, Easton DF, Dunning AM. (2013) 'Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers'. American Journal Of Human Genetics, 92 (4):489-503 [DOI] [Details]
(2013) 'miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy'
Kheirelseid, EAH,Miller, N,Chang, KH,Curran, C,Hennessey, E,Sheehan, M,Newell, J,Lemetre, C,Balls, G,Kerin, MJ (2013) 'miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy'. International Journal Of Colorectal Disease, 28 :247-260 [DOI] [Details]
(2013) 'Clinical applications of gene expression in colorectal cancer'
Kheirelseid EA, Miller N, Chang KH, Nugent M, Kerin MJ (2013) 'Clinical applications of gene expression in colorectal cancer'. Journal of gastrointestinal oncology, 4 (2):144-157 [DOI] [ARAN Link] [Details]
(2013) 'Large-scale genotyping identifies 41 new loci associated with breast cancer risk'
Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N; Breast and Ovarian Cancer Susceptibility Collaboration, Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer H, Adank M; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), van der Luijt RB, Hein R, Dahmen N, Beckman L, Meindl A, Schmutzler RK, Müller-Myhsok B, Lichtner P, Hopper JL, Southey MC, Makalic E, Schmidt DF, Uitterlinden AG, Hofman A, Hunter DJ, Chanock SJ, Vincent D, Bacot F, Tessier DC, Canisius S, Wessels LF, Haiman CA, Shah M, Luben R, Brown J, Luccarini C, Schoof N, Humphreys K, Li J, Nordestgaard BG, Nielsen SF, Flyger H, Couch FJ, Wang X, Vachon C, Stevens KN, Lambrechts D, Moisse M, Paridaens R, Christiaens MR, Rudolph A, Nickels S, Flesch-Janys D, Johnson N, Aitken Z, Aaltonen K, Heikkinen T, Broeks A, Veer LJ, van der Schoot CE, Guénel P, Truong T, Laurent-Puig P, Menegaux F, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Zamora MP, Perez JI, Pita G, Alonso MR, Cox A, Brock IW, Cross SS, Reed MW, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Henderson BE, Schumacher F, Le Marchand L, Andrulis IL, Knight JA, Glendon G, Mulligan AM; kConFab Investigators; Australian Ovarian Cancer Study Group, Lindblom A, Margolin S, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Bui QM, Stone J, Dite GS, Apicella C, Tsimiklis H, Giles GG, Severi G, Baglietto L, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Müller H, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Jones M, Figueroa J, Lissowska J, Brinton L, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Hamann U, Brüning T; GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Radice P, Peterlongo P, Manoukian S, Bonanni B, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Jakubowska A, Lubinski J, Jaworska K, Durda K, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Bogdanova NV, Antonenkova NN, Dörk T, Kristensen VN, Anton-Culver H, Slager S, Toland AE, Edge S, Fostira F, Kang D, Yoo KY, Noh DY, Matsuo K, Ito H, Iwata H, Sueta A, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Shu XO, Lu W, Gao YT, Cai H, Teo SH, Yip CH, Phuah SY, Cornes BK, Hartman M, Miao H, Lim WY, Sng JH, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Shen CY, Hsiung CN, Wu PE, Ding SL, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Blot WJ, Signorello LB, Cai Q, Zheng W, Deming-Halverson S, Shrubsole M, Long J, Simard J, Garcia-Closas M, Pharoah PD, Chenevix-Trench G, Dunning AM, Benitez J, Easton DF. (2013) 'Large-scale genotyping identifies 41 new loci associated with breast cancer risk'. Nature Genetics, 45 (4):353-361 [DOI] [ARAN Link] [Details]
(2013) 'Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer'
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F; Australian Cancer Study; Australian Ovarian Cancer Study; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab); Gene Environment Interaction and Breast Cancer (GENICA); Swedish Breast Cancer Study (SWE-BRCA); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), Vergote I, Lambrechts S, Despierre E, Risch HA, González-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Schoof N, Chang-Claude J, Cicek MS, Peto J, Kalli KR, Broeks A, Armasu SM, Schmidt MK, Braaf LM, Winterhoff B, Nevanlinna H...Tomlinson I, Kerin MJ, Miller N et al (2013) 'Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer'. Nature Genetics, 45 (4):371-384 [DOI] [ARAN Link] [Details]
(2013) 'Genome-wide association studies identify four ER negative-specific breast cancer risk loci'
Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, Brauch H, Chang-Claude J, Carpenter J, Godwin AK, Nevanlinna H, Giles GG, Cox A, Hopper JL, Bolla MK, Wang Q, Dennis J, Dicks E, Howat WJ, Schoof N, Bojesen SE, Lambrechts D, Broeks A, Andrulis IL, Guénel P, Burwinkel B, Sawyer EJ, Hollestelle A, Fletcher O, Winqvist R, Brenner H, Mannermaa A, Hamann U, Meindl A, Lindblom A, Zheng W, Devillee P, Goldberg MS, Lubinski J, Kristensen V, Swerdlow A, Anton-Culver H, Dörk T, Muir K, Matsuo K, Wu AH, Radice P, Teo SH, Shu XO, Blot W, Kang D, Hartman M, Sangrajrang S, Shen CY, Southey MC, Park DJ, Hammet F, Stone J, Veer LJ, Rutgers EJ, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Peto J, Schrauder MG, Ekici AB, Beckmann MW, Dos Santos Silva I, Johnson N, Warren H, Tomlinson I, Kerin MJ, Miller N et al. (2013) 'Genome-wide association studies identify four ER negative-specific breast cancer risk loci'. Nature Genetics, 45 (4):392-398 [DOI] [Details]
(2012) 'Systemic mirnas as potential biomarkers for malignancy'
Healy NA, Heneghan HM, Miller N, Osborne CK, Schiff R, Kerin MJ (2012) 'Systemic mirnas as potential biomarkers for malignancy'. International Journal Of Cancer, 131 (10):2215-2222 [DOI] [Details]
(2012) 'Relationship between circulating and tissue microRNAs in a murine model of breast cancer'
Waters PS, McDermott AM, Wall D, Heneghan HM, Miller N, Newell J, Kerin MJ and Dwyer RM. (2012) 'Relationship between circulating and tissue microRNAs in a murine model of breast cancer'. Plos One, 7 (11) [Details]
(2012) 'Circulating miR-34a levels are reduced in colorectal cancer'
Nugent M, Miller N, Kerin MJ (2012) 'Circulating miR-34a levels are reduced in colorectal cancer'. Journal Of Surgical Oncology, 106 (8):947-952 [Details]
(2012) 'Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer'
Waters, PS,McDermott, AM,Wall, D,Heneghan, HM,Miller, N,Newell, J,Kerin, MJ,Dwyer, RM (2012) 'Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer'. Plos One, 7 [DOI] [Details]
(2012) 'mRNA/miRNA correlations in colorectal cancer: novel mechanisms in cancer initiation and progression'
Kheirelseid EA, Miller N, Chang KH, Newell J, Kerin MJ (2012) 'mRNA/miRNA correlations in colorectal cancer: novel mechanisms in cancer initiation and progression'. International Journal Of Colorectal Disease, [DOI] [Details]
(2012) 'The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer'
Pilarski, R,Patel, DA,Weitzel, J,McVeigh, T,Dorairaj, JJ,Heneghan, HM,Miller, N,Weidhaas, JB,Kerin, MJ,McKenna, M,Wu, XF,Hildebrandt, M,Zelterman, D,Sand, S,Shulman, LP (2012) 'The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer'. Plos One, 7 (5) [DOI] [ARAN Link] [Details]
(2012) 'Circulating miR-34a levels are reduced in colorectal cancer'
Nugent, M,Miller, N,Kerin, MJ (2012) 'Circulating miR-34a levels are reduced in colorectal cancer'. Journal Of Surgical Oncology, 106 :947-952 [DOI] [Details]
(2012) 'Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer'
Glynn, RW,Miller, N,Mahon, S,Kerin, MJ (2012) 'Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer'. Oncol Rep, 28 (1):365-369 [DOI] [Details]
(2012) 'A review of expression profiling of circulating microRNAs in men with prostate cancer'
Kelly BD, Miller N, Healy NA, Walsh K, Kerin MJ (2012) 'A review of expression profiling of circulating microRNAs in men with prostate cancer'. Bju International, [DOI] [Details]
(2012) '11q13 is a susceptibility locus for hormone receptor positive breast cancer'
Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N et al. (2012) '11q13 is a susceptibility locus for hormone receptor positive breast cancer'. Human mutation, 33 (7):1123-1132 [DOI] [ARAN Link] [Details]
(2012) 'miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy'
Kheirelseid EA, Miller N, Chang KH, Curran C, Hennessy E, Sheehan M, Newell J, Lemetre C, Balls G, Kerin MJ (2012) 'miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy'. International Journal Of Colorectal Disease, [DOI] [Details]
(2012) 'Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)'
Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD; GENICA Network, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J; Kconfab Investigators; AOCS Group, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ME, Hooning M, Martens JW, Seynaeve C, Collée M, Hall P, Humpreys K, Czene K, Liu J, Cox A, Brock IW, Cross SS, Reed MW, Ahmed S, Ghoussaini M, Pharoah PD, Kang D, Yoo KY, Noh DY, Jakubowska A, Jaworska K, Durda K, Złowocka E, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Yu JC, Hsu HM, Hou MF, Orr N, Schoemaker M, Ashworth A, Swerdlow A, Trentham-Dietz A, Newcomb PA, Titus L, Egan KM, Chenevix-Trench G, Antoniou AC, Humphreys MK, Morrison J, Chang-Claude J, Easton DF, Dunning AM. (2012) 'Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)'. Plos One, 7 (8) [Details]
(2012) 'Relationship between circulating and tissue microRNAs in a murine model of breast cancer'
Waters PS, McDermott AM, Wall D, Heneghan HM, Miller N, Newell J, Kerin MJ and Dwyer RM. (2012) 'Relationship between circulating and tissue microRNAs in a murine model of breast cancer'. Plos One, 7 (11) [ARAN Link] [Details]
(2011) 'MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease'
Chang, KH,Miller, N,Kheirelseid, EAH,Lemetre, C,Ball, GR,Smith, MJ,Regan, M,McAnena, OJ,Kerin, MJ (2011) 'MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease'. International Journal Of Colorectal Disease, 26 (11):1415-1422 [DOI] [Details]
(2011) 'MicroRNA-21 and PDCD4 expression in colorectal cancer'
Chang, KH,Miller, N,Kheirelseid, EAH,Ingoldsby, H,Hennessy, E,Curran, CE,Curran, S,Smith, MJ,Regan, M,McAnena, OJ,Kerin, MJ (2011) 'MicroRNA-21 and PDCD4 expression in colorectal cancer'. European Journal Of Cancer, 37 :597-603 [DOI] [Details]
(2011) 'TOP2A Amplification in the Absence of That of HER-2/neu: Toward Individualization of Chemotherapeutic Practice in Breast Cancer'
Glynn, RW,Mahon, S,Curran, C,Callagy, G,Miller, N,Kerin, MJ (2011) 'TOP2A Amplification in the Absence of That of HER-2/neu: Toward Individualization of Chemotherapeutic Practice in Breast Cancer'. Oncologist, 16 (7):949-955 [DOI] [Details]
(2011) 'A 3 '-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis'
Paranjape, T,Heneghan, H,Lindner, R,Keane, FK,Hoffman, A,Hollestelle, A,Dorairaj, J,Geyda, K,Pelletier, C,Nallur, S,Martens, JWM,Hooning, MJ,Kerin, M,Zelterman, D,Zhu, Y,Tuck, D,Harris, L,Miller, N,Slack, F,Weidhaas, J (2011) 'A 3 '-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis'. Lancet Oncology, 12 (4):377-386 [DOI] [Details]
(2011) 'Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers'
Heneghan, HM,Miller, N,McAnena, OJ,O'Brien, T,Kerin, MJ (2011) 'Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers'. Journal Of Clinical Endocrinology & Metabolism, 96 :846-850 [DOI] [Details]
(2011) 'Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics'
Kheirelseid, EAH,Jumustafa, H,Miller, N,Curran, C,Sweeney, K,Malone, C,McLaughlin, R,Newell, J,Kerin, MJ (2011) 'Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics'. Breast Cancer Research And Treatment, 126 :131-140 [DOI] [Details]
(2011) 'Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Breast Cancer'
Milne, RL,Goode, EL,Garca-Closas, M,Couch, FJ,Severi, G,Hein, R,Fredericksen, Z,Malats, N,Zamora, MP,Perez, JIA,Benitez, J,Dork, T,Schurmann, P,Karstens, JH,Hillemanns, P,Cox, A,Brock, IW,Elliot, G,Cross, SS,Seal, S,Turnbull, C,Renwick, A,Rahman, N,Shen, CY,Yu, JC,Huang, CS,Hou, MF,Nordestgaard, BG,Bojesen, SE,Lanng, C,Alnaes, GG,Kristensen, V,Borrensen-Dale, AL,Hopper, JL,Dite, GS,Apicella, C,Southey, MC,Lambrechts, D,Yesilyurt, BT,Floris, G,Leunen, K,Sangrajrang, S,Gaborieau, V,Brennan, P,McKay, J,Chang-Claude, J,Wang-Gohrke, S,Radice, P,Peterlongo, P,Manoukian, S,Barile, M,Giles, GG,Baglietto, L,John, EM,Miron, A,Chanock, SJ,Lissowska, J,Sherman, ME,Figueroa, JD,Bogdanova, NV,Antonenkova, NN,Zalutsky, IV,Rogov, YI,Fasching, PA,Bayer, CM,Ekici, AB,Beckmann, MW,Brenner, H,Muller, H,Arndt (2011) 'Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Breast Cancer'. Cancer Epidemiology Biomarkers & Prevention, 20 :2222-2231 [DOI] [Details]
(2011) 'Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies'
Yang, XR,Chang-Claude, J,Goode, EL,Couch, FJ,Nevanlinna, H,Milne, RL,Gaudet, M,Schmidt, MK,Broeks, A,Cox, A,Fasching, PA,Hein, R,Spurdle, AB,Blows, F,Driver, K,Flesch-Janys, D,Heinz, J,Sinn, P,Vrieling, A,Heikkinen, T,Aittomaki, K,Heikkila, P,Blomqvist, C,Lissowska, J,Peplonska, B,Chanock, S,Figueroa, J,Brinton, L,Hall, P,Czene, K,Humphreys, K,Darabi, H,Liu, JJ,Van 't Veer, LJ,Van Leeuwen, FE,Andrulis, IL,Glendon, G,Knight, JA,Mulligan, AM,O'Malley, FP,Weerasooriya, N,John, EM,Beckmann, MW,Hartmann, A,Weihbrecht, SB,Wachter, DL,Jud, SM,Loehberg, CR,Baglietto, L,English, DR,Giles, GG,McLean, CA,Severi, G,Lambrechts, D,Vandorpe, T,Weltens, C,Paridaens, R,Smeets, A,Neven, P,Wildiers, H,Wang, XS,Olson, JE,Cafourek, V,Fredericksen, Z,Kosel, M,Vachon, C,Cramp, HE,Connley, D,Cross, SS,Balasubram (2011) 'Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies'. Journal Of The National Cancer Institute, 103 :250-263 [DOI] [Details]
(2011) 'MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers'
Nugent M, Miller N, Kerin MJ (2011) 'MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers'. Eur J Surg Oncol, 37 (8):649-654 [DOI] [Details]
(2011) 'The therapeutic potential of microRNAs: disease modulators and drug targets'
McDermott AM, Heneghan HM, Miller N, Kerin MJ (2011) 'The therapeutic potential of microRNAs: disease modulators and drug targets'. Pharmaceutical research, 28 (12):3016-3029 [DOI] [Details]
(2011) 'Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics'
Kheirelseid EA, Jumustafa H, Miller N, Curran C, Sweeney K, Malone C, McLaughlin R, Newell J, Kerin MJ. (2011) 'Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics'. Breast Cancer Res Treat, 126 :131-140 [Details]
(2011) 'Circulating microRNAs: promising breast cancer biomarkers'
Heneghan HM, Miller N, Kerin MJ. (2011) 'Circulating microRNAs: promising breast cancer biomarkers'. Breast Cancer Research, 13 (1) [Details]
(2011) 'MicroRNA-21 and PDCD4 expression in colorectal cancer'
Chang KH, Miller N, Kheirelseid EA, Ingoldsby H, Hennessy E, Curran CE, Curran S, Smith MJ, Regan M, McAnena OJ, Kerin MJ (2011) 'MicroRNA-21 and PDCD4 expression in colorectal cancer'. Eur J Surg Oncol, 37 (7):597-603 [Details]
(2011) 'The therapeutic potential of microRNAs: disease modulators and drug targets'
McDermott AM, Heneghan HM, Miller N, Kerin MJ. (2011) 'The therapeutic potential of microRNAs: disease modulators and drug targets'. Pharm Res, 28 (12):3016-3029 [Details]
(2011) 'A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis'
Paranjape T, Heneghan H, Lindner R, Keane FK, Hoffman A, Hollestelle A, Dorairaj J, Geyda K, Pelletier C, Nallur S, Martens JW, Hooning MJ, Kerin M, Zelterman D, Zhu Y, Tuck D, Harris L, Miller N, Slack F, Weidhaas J (2011) 'A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis'. Lancet, 12 (4):377-386 [DOI] [Details]
(2011) 'Circulating microRNAs: promising breast cancer Biomarkers'
Heneghan HM, Miller N, Kerin MJ (2011) 'Circulating microRNAs: promising breast cancer Biomarkers'. Breast Cancer Research, 13 (1) [DOI] [Details]
(2010) 'Dysregulated miR-183 inhibits migration in breast cancer cells'
Lowery, AJ, Miller, N, Dwyer, RM, Kerin, MJ (2010) 'Dysregulated miR-183 inhibits migration in breast cancer cells'. BMC Cancer, 10 [DOI] [Details]
(2010) 'Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort'
McInerney, NM,Miller, N,Rowan, A,Colleran, G,Barclay, E,Curran, C,Kerin, MJ,Tomlinson, IP,Sawyer, E (2010) 'Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort'. Breast Cancer Research And Treatment, 121 :203-210 [DOI] [Details]
(2010) 'Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)''
Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ (2010) 'Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)''. Breast Cancer Res Treat, 124 (2):317-326 [Details]
(2010) 'MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer'
Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N. (2010) 'MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer'. BMC Cancer, 10 [Details]
(2010) 'Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer'
Kheirelseid EA, Chang KH, Newell J, Kerin MJ, Miller N. (2010) 'Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer'. BMC Mol Biol, 11 [Details]
(2010) '17q12-21 - The pursuit of targeted therapy in breast cancer'
Glynn RW, Miller N, Kerin MJ (2010) '17q12-21 - The pursuit of targeted therapy in breast cancer'. Cancer Treat Rev, 36 (3):224-229 [Details]
(2010) 'Authorship trends in the surgical literature'
Glynn, RW,Kerin, MJ,Sweeney, KJ (2010) 'Authorship trends in the surgical literature'. British Journal Of Surgery, 97 (8):1304-1308 [DOI] [Details]
(2010) 'Circulating miRNA signatures: promising prognostic tools for cancer'
Heneghan HM, Miller N, Kerin MJ. (2010) 'Circulating miRNA signatures: promising prognostic tools for cancer'. J Clin Oncol, 28 (29):573-574 [Details]
(2010) 'Systemic microRNAs: novel biomarkers for colorectal and other cancers?'
Heneghan HM, Miller N, Kerin MJ (2010) 'Systemic microRNAs: novel biomarkers for colorectal and other cancers?'. Gut, 59 (7):1002-101 [DOI] [Details]
(2010) 'MiRNAs as biomarkers and therapeutic targets in cancer'
Heneghan, HM,Miller, N,Kerin, MJ (2010) 'MiRNAs as biomarkers and therapeutic targets in cancer'. Curr Opin Pharmacol, 10 (5):543-550 [DOI] [Details]
(2010) 'Role of microRNAs in obesity and the metabolic syndrome'
Heneghan, HM,Miller, N,Kerin, MJ (2010) 'Role of microRNAs in obesity and the metabolic syndrome'. Obes Rev, 11 (5):354-361 [DOI] [Details]
(2010) 'Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease'
Heneghan, HM,Miller, N,Kelly, R,Newell, J,Kerin, MJ (2010) 'Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease'. Oncologist, 15 (7):673-682 [DOI] [Details]
(2010) 'Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)'
Martin, FT,Dwyer, RM,Kelly, J,Khan, S,Murphy, JM,Curran, C,Miller, N,Hennessy, E,Dockery, P,Barry, FP,O'Brien, T,Kerin, MJ (2010) 'Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)'. Breast Cancer Research And Treatment, 124 :317-326 [DOI] [Details]
(2010) 'Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy'
Glynn, RW,Miller, N,Whelan, MC,Kerin, MJ (2010) 'Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy'. Annals Of Surgical Oncology, 17 (5):1392-1397 [DOI] [Details]
(2010) 'Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer'
Heneghan, HM,Miller, N,Lowery, AJ,Sweeney, KJ,Newell, J,Kerin, MJ (2010) 'Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer'. Ann Surg, 251 :499-505 [DOI] [Details]
(2010) 'The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer'
Colleran, G,McInerney, N,Rowan, A,Barclay, E,Jones, AM,Curran, C,Miller, N,Kerin, M,Tomlinson, I,Sawyer, E (2010) 'The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer'. Breast Cancer Research And Treatment, 119 (2):437-442 [DOI] [Details]
(2010) 'MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer'
Chang, KH,Mestdagh, P,Vandesompele, J,Kerin, MJ,Miller, N (2010) 'MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer'. BMC Cancer, 10 [DOI] [Details]
(2010) 'Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer'
Kheirelseid, EAH,Chang, KH,Newell, J,Kerin, MJ,Miller, N (2010) 'Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer'. BMC Molecular Biology, 11 [DOI] [Details]
(2009) 'Low penetrance breast cancer predisposition SNPs are site specific'
Mcinerney N, Colleran G, Rowan A, Walther A, Barclay E, Spain S, Jones AM, Tuohy S, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. (2009) 'Low penetrance breast cancer predisposition SNPs are site specific'. Breast Cancer Res Treat, 117 (1):151-159 [DOI] [Details]
(2009) 'Low penetrance breast cancer predisposition SNPs are site specific'
Mcinerney N, Colleran G, Rowan A, Walther A, Barclay E, Spain S, Jones AM, Tuohy S, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E (2009) 'Low penetrance breast cancer predisposition SNPs are site specific'. Breast Cancer Research, 117 (1):151-159 [DOI] [Details]
(2009) 'Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer'
McCafferty, M. P. J.,McNeill, R. E.,Miller, N.,Kerin, M. J. (2009) 'Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer'. Breast Cancer Research and Treatment, 116 (33):425-432 [Details]
(2009) 'Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer'
McCafferty MP, McNeill RE, Miller N, Kerin MJ. (2009) 'Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer'. Breast Cancer Res Treat, 116 (3):425-432 [Details]
(2009) 'MicroRNAs as Novel Biomarkers for Breast Cancer'
Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Kerin MJ (2009) 'MicroRNAs as Novel Biomarkers for Breast Cancer'. Journal of oncology, 2009 [DOI] [Details]
(2009) 'MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer'
Lowery, AJ,Miller, N,Devaney, A,McNeill, RE,Davoren, PA,Lemetre, C,Benes, V,Schmidt, S,Blake, J,Ball, G,Kerin, MJ (2009) 'MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer'. Breast Cancer Research, 11 (3) [DOI] [Details]
(2008) 'MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management'
Lowery, A. J., Miller, N., McNeill, R. E. & Kerin, M. J. (2008) 'MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management'. Clinical Cancer Research, 14 (2):360-365 [Details]
(2008) 'Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner'
Bretschneider, N., Brand, H., Miller, N., Lowery, A. J., Kerin, M. J., Gannon, F. & Denger, S. (2008) 'Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner'. Cancer Research, 68 (1):106-114 [Details]
(2008) 'Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner'
Bretschneider, N,Brand, H,Miller, N,Lowery, AJ,Kerin, MJ,Gannon, F,Denger, S (2008) 'Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner'. Cancer Research, 68 :106-114 [DOI] [Details]
(2008) 'Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer'
Davoren, PA,McNeill, RE,Lowery, AJ,Kerin, MJ,Miller, N (2008) 'Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer'. BMC Molecular Biology, 9 [DOI] [Details]
(2007) 'Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer'
McNeill, R. E., Miller, N. & Kerin, M. J. (2007) 'Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer'. BMC Mol Biol, 8 [Details]
(2007) 'Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer'
McNeill, RE,Miller, N,Kerin, MJ (2007) 'Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer'. BMC Molecular Biology, 8 [DOI] [Details]
(2007) 'Molecular profiling techniques and bioinformatics in cancer research'
Manning, A. T., Garvin, J. T., Shahbazi, R. I., Miller, N., McNeill, R. E. & Kerin, M. J. (2007) 'Molecular profiling techniques and bioinformatics in cancer research'. European Journal Of Surgical Oncology, 33 (3):255-265 [Details]
(1997) 'The MAS proto-oncogene is imprinted in human breast tissue'
Miller, N,McCann, AH,O'Connell, D,Pedersen, IS,Spiers, V,Gorey, T,Dervan, PA (1997) 'The MAS proto-oncogene is imprinted in human breast tissue'. Genomics, 46 :509-512 [Details]
(1996) 'Biallelic expression of the IGF2 gene in human breast disease'
McCann, AH,Miller, N,OMeara, A,Pedersen, I,Keogh, K,Gorey, T,Dervan, PA (1996) 'Biallelic expression of the IGF2 gene in human breast disease'. Human Molecular Genetics, 5 :1123-1127 [Details]

Book Chapters

  Year Publication
(2013) 'MiRNAs as potential therapeutic targets in cancer'
McDermott AM, Heneghan HM, Miller N, Kerin MJ (2013) 'MiRNAs as potential therapeutic targets in cancer' In: MicroRNAs in Cancer. USA: CRC Press. [Details]

Conference Publications

  Year Publication
(2009) San Antonio Breast Cancer Symposium 2008
McCafferty, M. P. J.,McNeill, R. E.,Miller, N.,Kerin, M. J. (2009) Relationships between estrogen receptor co-regulators and intrinsic subtypes in breast cancer San Antonio Breast Cancer Symposium 2008 [Details]
(2009) The microvasculature of invasive ductal breast carcinoma: a sterological approach
Mahon, S.,Miller, N.,Curran, C.,Dockery, P.,Callagy, G.,Kerin, M. J. (2009) Cancer Research The microvasculature of invasive ductal breast carcinoma: a sterological approach [Details]

Abstract

  Year Publication
(2011) Expression of genes related to neurotrophin signalling in breast cancer - in search of novel therapeutic techniques.
Helen, E,Healy, N,Gorman, A,Miller, N,Kerin, MJ (2011) Expression of genes related to neurotrophin signalling in breast cancer - in search of novel therapeutic techniques. Abstract [Details]
(2010) Clinical applications of molecular profiling of colorectal cancer.
Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2010) Clinical applications of molecular profiling of colorectal cancer. Abstract [Details]
(2010) ANN Analysis to Identify MicroRNA Expression Patterns in Colorectal Cancer.
Chang, K,Miller, N,Kheirelseid, E,Ball, G,Smith, MJ,Regan, M,McAnena, OJ,Kerin, MJ (2010) ANN Analysis to Identify MicroRNA Expression Patterns in Colorectal Cancer. Abstract [Details]
(2009) MicroRNA expression profile in stage II colorectal cancer.
Chang, KH,Miller, N,Kerin, MJ (2009) MicroRNA expression profile in stage II colorectal cancer. Abstract [Details]
(2009) Evaluation of proposed candidate genetic variants in a west of Ireland breast cancer cohort.
McInerney, N,Miller, N,Rowan, A,Colleran, G,Curran, C,Sawyer, E,Tomlinson, IP,Kerin, MJ (2009) Evaluation of proposed candidate genetic variants in a west of Ireland breast cancer cohort. Abstract [Details]
(2009) The microvasculature of invasive ductal breast carcinoma: a sterological approach.
Mahon, S,Miller, N,Curran, C,Dockery, P,Callagy, G,Kerin, MJ (2009) The microvasculature of invasive ductal breast carcinoma: a sterological approach. Abstract [Details]
(2009) Low penetrance breast cancer predisposition SNPs are site specific.
Mc Inerney, NM,Colleran, G,Walther, A,Rowan, A,Spain, S,Jones, AM,Tuohy, S,Barclay, E,Curran, C,Miller, N,Kerin, MJ,Tomlinson, I,Eli, S (2009) Low penetrance breast cancer predisposition SNPs are site specific. Abstract [Details]
(2009) Increased systemic microRNAs in breast cancer correlate with tumour microRNA profile and clinicopathologic characteristics.
Heneghan, HM,Miller, N,Kerin, MJ (2009) Increased systemic microRNAs in breast cancer correlate with tumour microRNA profile and clinicopathologic characteristics. Abstract [Details]
(2009) Bilateral Breast Cancer: Analysis of Incidence, Characteristics and Outcome of the Disease.
Kheirelseid, EAH,Jumastapha, H,Miller, N,Curran, C,Sweeney, KJ,Newell, J,Kerin, MJ (2009) Bilateral Breast Cancer: Analysis of Incidence, Characteristics and Outcome of the Disease. Abstract [Details]
(2009) Systemic MiRNA Levels as Novel Breast Cancer Biomarkers.
Heneghan, HM,Miller, N,Newell, J,Kerin, MJ (2009) Systemic MiRNA Levels as Novel Breast Cancer Biomarkers. Abstract [Details]
(2009) Evaluation of variants in BRIP1, PALB2 and CHEK2 in a west of Ireland breast cancer cohort.
Mc Inerney, NM,Miller, N,Rowan, A,Colleran, G,Curran, C,Ian, T,Eli, S,Michael, KJ (2009) Evaluation of variants in BRIP1, PALB2 and CHEK2 in a west of Ireland breast cancer cohort. Abstract [Details]
(2007) MicroRNA expression in primary breast tumors.
Aj, L,Miller, N,Re, M,Mj, K (2007) MicroRNA expression in primary breast tumors. Abstract [Details]
(2007) Expression of the putative breast cancer gene breast cancer and salivary gland expression; relationship with microRNA 154*and estrogen receptor status.
Aj, L,Miller, N,Mj, K (2007) Expression of the putative breast cancer gene breast cancer and salivary gland expression; relationship with microRNA 154*and estrogen receptor status. Abstract [Details]
(2007) Micro-RNA expression profiling in primary breast tumours.
Lowery, AJ,Miller, N,McNeill, RE,Kerin, MJ (2007) Micro-RNA expression profiling in primary breast tumours. Abstract [Details]
(2007) Expression of the putative breast cancer gene BASE; relationship with microRNA 154* and estrogen receptor status.
Lowery, AJ,Miller, N,Kerin, MJ (2007) Expression of the putative breast cancer gene BASE; relationship with microRNA 154* and estrogen receptor status. Abstract [Details]
(2007) The identification and validation of novel endogenous control genes for the analysis of gene expression data in breast cancer tissues by real-time quantitative PCR.
McNeill, RE,Miller, N,Kerin, MJ (2007) The identification and validation of novel endogenous control genes for the analysis of gene expression data in breast cancer tissues by real-time quantitative PCR. Abstract [Details]
(2007) The CHEK2*1100deIC variant: present in the west of Ireland breast cancer population.
Colleran, GC,Rowan, A,Miller, N,Sawyer, E,Curran, C,Kerin, M,Tomlinson, I (2007) The CHEK2*1100deIC variant: present in the west of Ireland breast cancer population. Abstract [Details]

Letter

  Year Publication
(2011) Association between KRAS rs61764370 and triple-negative breast cancer-a false positive? reply.
Weidhaas, J,Slack, F,Miller, N,Harris, L,Tuck, D,Zhu, Y,Zelterman, D,Kerin, M,Paranjape, T,Heneghan, H,Lindner, R,Keane, F,Dorairaj, J,Geyda, K,Pelletier, C,Nallur, S (2011) Association between KRAS rs61764370 and triple-negative breast cancer-a false positive? reply. Letter [Details]
(2011) Circulating microRNAs: promising breast cancer biomarkers.
Heneghan, HM,Miller, N,Kerin, MJ (2011) Circulating microRNAs: promising breast cancer biomarkers. Letter [DOI] [Details]
(2010) Systemic microRNAs: novel biomarkers for colorectal and other cancers?.
Heneghan, HM,Miller, N,Kerin, MJ (2010) Systemic microRNAs: novel biomarkers for colorectal and other cancers?. Letter [DOI] [Details]
(2010) Circulating miRNA Signatures: Promising Prognostic Tools for Cancer.
Heneghan, HM,Miller, N,Kerin, MJ (2010) Circulating miRNA Signatures: Promising Prognostic Tools for Cancer. Letter [DOI] [Details]

Meeting

  Year Publication
(2013) MiR-15 family microRNAs: Aberrant expression in breast cancer.
McDermott, AM,Heneghan, HM,Wall, D,Miller, N,Kerin, MJ (2013) MiR-15 family microRNAs: Aberrant expression in breast cancer. Meeting [Details]
(2012) Identification and validation of novel circulating microRNA biomarkers for Luminal A breast cancer.
McDermott, A,Miller, N,Sweeney, K,Ball, G,Kerin, M (2012) Identification and validation of novel circulating microRNA biomarkers for Luminal A breast cancer. Meeting [Details]
(2012) Identification and validation of novel microRNA oncologic biomarkers of Luminal-A breast cancer.
McDermott, AM,Miller, N,Sweeney, KJ,Ball, G,Kerin, MJ (2012) Identification and validation of novel microRNA oncologic biomarkers of Luminal-A breast cancer. Meeting [Details]
(2012) The role of miRNAs in tamoxifen resistance in breast cancer.
Healy, NA,Schiff, R,Miller, N,Osborne, CK,Kerin, MJ (2012) The role of miRNAs in tamoxifen resistance in breast cancer. Meeting [Details]
(2012) Identification of Novel MicroRNA Biomarkers for Detection of Luminal a Breast Cancer.
McDermott, AM,Miller, N,Ball, G,Sweeney, KJ,Kerin, MJ (2012) Identification of Novel MicroRNA Biomarkers for Detection of Luminal a Breast Cancer. Meeting [Details]
(2012) Circulating MicroRNA signatures: A novel minimally invasive biomarker for prostate cancer.
Kelly, BD,Miller, N,Durkan, GC,Sweeney, KJ,Rogers, E,Walsh, K,Kerin, MJ (2012) Circulating MicroRNA signatures: A novel minimally invasive biomarker for prostate cancer. Meeting [Details]
(2012) Circulating miR-497 as a novel minimally invasive biomarker for breast cancer.
Walsh, JW,McDermott, AM,Miller, N,Sweeney, KJ,Kerin, MJ (2012) Circulating miR-497 as a novel minimally invasive biomarker for breast cancer. Meeting [Details]
(2012) Circulating miR-141 as a diagnostic biomarker for prostate cancer and for monitoring response to treatment.
Kelly, BD,Miller, N,Sweeney, KJ,Durkan, GC,Rogers, E,Walsh, K,Kerin, MJ (2012) Circulating miR-141 as a diagnostic biomarker for prostate cancer and for monitoring response to treatment. Meeting [Details]
(2012) Differential Expression Of miR-15 Family Members in Breast Cancer.
McDermott, AM,Walsh, J,Heneghan, HM,Wall, D,Miller, N,Kerin, MJ (2012) Differential Expression Of miR-15 Family Members in Breast Cancer. Meeting [Details]
(2011) A 3 ' UTR variant in BRCA1: a predictor of poor outcome in breast cancer.
Dorairaj, JJ,Miller, N,Wall, D,Newell, J,Weidhaas, JB,Kerin, MJ (2011) A 3 ' UTR variant in BRCA1: a predictor of poor outcome in breast cancer. Meeting [Details]
(2011) Expression profiling of circulating miRNAs in breast cancer.
Healy, NA,Heneghan, HM,Lowery, AJ,Miller, N,Kerin, MJ (2011) Expression profiling of circulating miRNAs in breast cancer. Meeting [Details]
(2011) Clinicopathological variables of BRCA 1 and 2 gene mutations in the west of Ireland population.
Dorairaj, JJ,Irwin, R,Wall, D,Cody, N,Miller, N,Sweeney, KJ,Green, A,Kerin, MJ (2011) Clinicopathological variables of BRCA 1 and 2 gene mutations in the west of Ireland population. Meeting [Details]
(2011) MIRNA signatures as predictors of resistance to endocrine and HER2 targeted therapy.
Healy, NA,Schiff, R,Osborne, CK,Miller, N,Kerin, MJ (2011) MIRNA signatures as predictors of resistance to endocrine and HER2 targeted therapy. Meeting [Details]
(2011) Molecular profiling of colorectal cancer: Does it apply clinically?.
Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2011) Molecular profiling of colorectal cancer: Does it apply clinically?. Meeting [Details]
(2011) Circulating miRNAs as blood based markers for prostate cancer.
Kelly, BD,Miller, N,Durkan, GC,Sweeney, KJ,Rogers, E,Walsh, K,Kerin, MJ (2011) Circulating miRNAs as blood based markers for prostate cancer. Meeting [Details]
(2010) Identification of potential therapeutic targets at the HER2/NEU amplicon.
Glynn, RW,Miller, N,Mahon, S,Doolin, O,Curran, C,Kerin, MJ (2010) Identification of potential therapeutic targets at the HER2/NEU amplicon. Meeting [Details]
(2010) A KRAS MICRORNA BINDING SITE VARIANT IS A GENETIC MARKER OF RISK FOR TRIPLE NEGATIVE BREAST CANCER.
Heneghan, HM,Miller, N,Paranjape, T,Slack, FJ,Weidhaas, JB,Kerin, MJ (2010) A KRAS MICRORNA BINDING SITE VARIANT IS A GENETIC MARKER OF RISK FOR TRIPLE NEGATIVE BREAST CANCER. Meeting [DOI] [Details]
(2010) DYSREGULATED CANCER-SPECIFIC MiRNAs IN THE CIRCULATION OF BREAST CANCER PATIENTS.
Healy, NA,Heneghan, HM,Lowery, AJ,Miller, N,Kerin, MJ (2010) DYSREGULATED CANCER-SPECIFIC MiRNAs IN THE CIRCULATION OF BREAST CANCER PATIENTS. Meeting [DOI] [Details]
(2010) 17Q12-21: HER2/NEU, TOP2A, AND THE CASE FOR INDIVIDUALISED THERAPY IN BREAST CANCER.
Glynn, RW,Miller, N,Mahon, S,Doolin, O,Curran, C,Kerin, MJ (2010) 17Q12-21: HER2/NEU, TOP2A, AND THE CASE FOR INDIVIDUALISED THERAPY IN BREAST CANCER. Meeting [Details]
(2010) EXPRESSION OF MICRORNAS AND THEIR PREDICTED PROTEIN TARGETS IN THE CIRCULATION OF BREAST CANCER PATIENTS: NOVEL BIOMARKERS FOR BREAST CANCER.
Kelly, RJ,Heneghan, HM,Miller, N,Kerin, MJ (2010) EXPRESSION OF MICRORNAS AND THEIR PREDICTED PROTEIN TARGETS IN THE CIRCULATION OF BREAST CANCER PATIENTS: NOVEL BIOMARKERS FOR BREAST CANCER. Meeting [Details]
(2010) CIRCULATING microRNAs IN COLORECTAL CANCER.
Nugent, M,Kheirelseid, EAH,Heneghan, HM,Chang, KH,Miller, N,Kerin, MJ (2010) CIRCULATING microRNAs IN COLORECTAL CANCER. Meeting [Details]
(2010) EXPRESSION PROFILING OF SYSTEMICALLY EXPRESSED BREAST CANCER-SPECIFIC miRNAS.
Healy, NA,Heneghan, HM,Miller, N,Kerin, MJ (2010) EXPRESSION PROFILING OF SYSTEMICALLY EXPRESSED BREAST CANCER-SPECIFIC miRNAS. Meeting [Details]
(2010) A SYSTEMIC MIRNA SIGNATURE PREDICTIVE OF EARLY BREAST CANCER.
Heneghan, HM,Miller, N,Kelly, R,Nugent, M,Kerin, MJ (2010) A SYSTEMIC MIRNA SIGNATURE PREDICTIVE OF EARLY BREAST CANCER. Meeting [Details]
(2010) A SNP IN LET-7 MIRNA BINDING SITE IN THE KRAS ONCOGENE INCREASES RISK OF TRIPLE NEGATIVE BREAST CANCER.
Heneghan, HM,Miller, N,Paranjape, T,Slack, FJ,Weidhaas, JB,Kerin, MJ (2010) A SNP IN LET-7 MIRNA BINDING SITE IN THE KRAS ONCOGENE INCREASES RISK OF TRIPLE NEGATIVE BREAST CANCER. Meeting [Details]
(2010) MOLECULAR PROFILING OF COLORECTAL CANCER.
Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2010) MOLECULAR PROFILING OF COLORECTAL CANCER. Meeting [Details]
(2010) Bilateral breast cancer: do synchronous and metachronous tumours represent different disease entities?.
Kheirelseid, EAH,Jumastapha, H,Miller, N,Curran, C,Sweeney, K,Kerin, MJ (2010) Bilateral breast cancer: do synchronous and metachronous tumours represent different disease entities?. Meeting [Details]
(2010) Liver-intestinal cadherin (CDH17) is downregulated in colorectal cancer and associated with tumour progression.
Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2010) Liver-intestinal cadherin (CDH17) is downregulated in colorectal cancer and associated with tumour progression. Meeting [Details]
(2009) Characterisation of 17q12-21-Identification of Novel Therapeutic Targets.
Glynn, RW,Miller, N,Iglesias, EA,Doolin, O,Newell, J,Kerin, MJ (2009) Characterisation of 17q12-21-Identification of Novel Therapeutic Targets. Meeting [Details]
(2007) MMP9 IS ASSOCIATED WITH POOR OUTCOME IN BREAST CANCER WHILE MMP9 AND MMP11 EXPRESSION ARE INCREASED IN OESTROGEN RECEPTOR POSITIVE BREAST CANCER.
Garvin, JT,McNeill, RE,Hennessy, E,Miller, N,Kerin, MJ (2007) MMP9 IS ASSOCIATED WITH POOR OUTCOME IN BREAST CANCER WHILE MMP9 AND MMP11 EXPRESSION ARE INCREASED IN OESTROGEN RECEPTOR POSITIVE BREAST CANCER. Meeting [Details]
(2007) GATA3 AND BAG1 OVER-EXPRESSION ARE ASSOCIATED WITH GOOD PROGNOSIS IN NODE NEGATIVE BREAST CANCER.
Garvin, JT,McNeill, RE,Hennessy, E,Miller, N,Kerin, MJ (2007) GATA3 AND BAG1 OVER-EXPRESSION ARE ASSOCIATED WITH GOOD PROGNOSIS IN NODE NEGATIVE BREAST CANCER. Meeting [Details]
(2007) Gene expression profiling of axillary node negative tumour tissues using microarrays to inform prognosis in breast cancer.
Garvin, JT,McNeill, RE,Hennessy, E,Miller, N,Kerin, MJ (2007) Gene expression profiling of axillary node negative tumour tissues using microarrays to inform prognosis in breast cancer. Meeting [Details]
(2007) Characterisation of specific micro-RNA expression profiles in fresh frozen human breast tissue.
Davoren, PA,Miller, N,McNeill, R,Kerin, MJ (2007) Characterisation of specific micro-RNA expression profiles in fresh frozen human breast tissue. Meeting [Details]
(2006) Cathepsin K gene expression and breast cancer metastases.
Manning, AT,Garvin, JT,McNeill, RE,Miller, N,Hennessy, E,Kerin, MJ (2006) Cathepsin K gene expression and breast cancer metastases. Meeting [Details]
(1998) Mono-allelic expression of the Mas proto-oncogene in human breast tissue.
Miller, N,McCann, A,O'Connell, D,Pedersen, IS,Spiers, V,Gorey, T,Dervan, PA (1998) Mono-allelic expression of the Mas proto-oncogene in human breast tissue. Meeting [Details]

Reviews

  Year Publication
(2013) A review of expression profiling of circulating microRNAs in men with prostate cancer.
Kelly, BD,Miller, N,Healy, NA,Walsh, K,Kerin, MJ (2013) A review of expression profiling of circulating microRNAs in men with prostate cancer. Reviews [DOI] [Details]
(2012) Systemic mirnas as potential biomarkers for malignancy.
Healy, NA,Heneghan, HM,Miller, N,Osborne, CK,Schiff, R,Kerin, MJ (2012) Systemic mirnas as potential biomarkers for malignancy. Reviews [DOI] [Details]
(2011) MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers.
Nugent, M,Miller, N,Kerin, MJ (2011) MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers. Reviews [DOI] [Details]
(2011) The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug Targets.
McDermott, AM,Heneghan, HM,Miller, N,Kerin, MJ (2011) The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug Targets. Reviews [DOI] [Details]
(2010) 17q12-21-The pursuit of targeted therapy in breast cancer.
Glynn, RW,Miller, N,Kerin, MJ (2010) 17q12-21-The pursuit of targeted therapy in breast cancer. Reviews [DOI] [Details]
(2009) Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer.
McCafferty, MPJ,McNeill, RE,Miller, N,Kerin, MJ (2009) Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. Reviews [DOI] [Details]
(2008) MicroRNAs as prognostic indicators and therapeutic targets: Potential effect on breast cancer management.
Lowery, AJ,Miller, N,McNeill, RE,Kerin, MJ (2008) MicroRNAs as prognostic indicators and therapeutic targets: Potential effect on breast cancer management. Reviews [DOI] [Details]
(2007) Molecular profiling techniques and bioinformatics in cancer research.
Manning, AT,Garvin, JT,Shahbazi, RI,Miller, N,McNeill, RE,Kerin, MJ (2007) Molecular profiling techniques and bioinformatics in cancer research. Reviews [DOI] [Details]

Teaching Interests

Cancer Genetics
Biobanking